Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis

Cancer Biology and Therapy

Volumn 4, Issue 12, 2005, Pages 1395-1400

  Tsai, Jeff H ^a   Makonnen, Sosina ^b   Feldman, Michael ^a   Sehgal, Chandra M ^a   Maity, Amit ^a   Lee, William M F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiogenesis inhibition; Radiation therapy

Indexed keywords

FS 069; KI 67 ANTIGEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; FEMALE; HYPOXIA; IONIZING RADIATION; MELANOMA; MICROVASCULATURE; MOUSE; NICK END LABELING; NONHUMAN; PERFUSION; PROTEIN INDUCTION; RADIATION RESPONSE; TISSUE INJURY; TUMOR VASCULARIZATION; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; COMPARATIVE STUDY; EXPERIMENTAL MELANOMA; NEOVASCULARIZATION (PATHOLOGY); RADIATION DOSE FRACTIONATION; TIME; VASCULARIZATION;

ANIMALS; DOSE FRACTIONATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RADIATION, IONIZING; TIME FACTORS;

EID: 31144449264     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.12.2331     Document Type: Article

References (46)

1. Konski A, Feigenberg S, Chow E. Palliative radiation therapy. Semin Oncol 2005; 32:156-64.
2. Bernier J, Hall EJ, Giaccia A. Radiation oncology: A century of achievements. Nat Rev Cancer 2004; 4:737-47.
3. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33:781-96.
4. Shinomiya N. New concepts in radiation-induced apoptosis: 'Premitotic apoptosis' and 'postmitotic apoptosis. J Cell Mol Med 2001; 5:240-53.
5. Zanelli GD, Lucas PB. Effects of X-rays on vascular function in transplanted tumours and normal tissues in the mouse. Br J Cancer 1976; 34:408-17.
6. Baker DG, Krochak RJ. The response of the microvascular system to radiation: A review. Cancer Invest 1989; 7:287-94.
7. Paris F, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293:293-7.
8. Maj JG, et al. Microvascular function regulates intestinal crypt response to radiation. Cancer Res 2003; 63:4338-41.
9. Garcia-Barros M, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300:1155-9.
10. Folkman J, Camphausen K. Cancer. What does radiotherapy do to endothelial cells? Science 2001; 293:227-8.
11. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-57.
12. Geng L, et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 2001; 61:2413-9.
13. Schueneman AJ, et al. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res 2003; 63:4009-16.
14. Winkler F, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004; 6:553-63.
15. Moeller BJ, et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005; 8:99-110.
16. Gee MS, et al. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12. Cancer Res 1999; 59:4882-9.
17. Gee MS, et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001; 61:2974-82.
18. Ziemer LS, Lee WM, Vinogradov SA, Sehgal C, Wilson DF. Oxygen distribution in murine tumors: Characterization using oxygen-dependent quenching of phosphorescence. J Appl Physiol 2005; 98:1503-10.
19. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147:9-19.
20. Lord EM, Harwell L, Koch CJ. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res 1993; 53:5721-6.
21. Gee MS, Lee WM. The role of tumor oxygenation in vascular and clinical response to angiogenesis inhibition. Adv Exp Med Biol 2003; 510:1-5.
22. Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004; 5:429-41.
23. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2:38-47.
24. Gee MS, et al. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am J Pathol 2003; 162:183-93.
25. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004; 4:604-16.
26. McBride WH, et al. A sense of danger from radiation. Radiat Res 2004; 162:1-19.
27. Oh CW, Bump EA, Kim JS, Janigro D, Mayberg MR. Induction of a senescence-like phenotype in bovine aortic endothelial cells by ionizing radiation. Radiat Res 2001; 156:232-40.
28. Lee JC, et al. Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas. Cancer Res 2002; 62:747-55.
29. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003; 111:1287-95.
30. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125:1591-8.
31. Inai T, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004; 165:35-52.
32. Gee MS, et al. Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition. Cancer Res 2003; 63:8073-8.
33. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390:404-7.
34. O'Reilly MS, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79:315-28.
35. Wachsberger PR, et al. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res 2005; 11:835-42.
36. Shi W, Teschendorf C, Muzyczka N, Siemann DW. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol 2003; 66:1-9.
37. Huang SM, Li J, Armstrong EA, Harari PM. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 2002; 62:4300-6.
38. Siemann DW, Rojiani AM. Enhancement of radiation therapy by the novel vascular targeting agent ZD6126. Int J Radiat Oncol Biol Phys 2002; 53:164-71.
39. Hess C, et al. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer 2001; 85:2010-6.
40. Kozin SV, et al. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res 2001; 61:39-44.
41. Lee CG, et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000; 60:5565-70.
42. Griscelli F, et al. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci USA 2000; 97:6698-703.
43. Lund EL, Bastholm L, Kristjansen PE. Therapeutic synergy of TNP-470 and ionizing radiation: Effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. Clin Cancer Res 2000; 6:971-8.
44. Gorski DH, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999; 59:3374-8.
45. Mauceri HJ, et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998; 394:287-91.
46. Murata R, Nishimura Y, Hiraoka M. An antiangiogenie agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma. Int J Radiat Oncol Biol Phys 1997; 37:1107-13.